Home
Mail
News
Sports
Finance
Celebrity
Style
Movies
Weather
Mobile
Yahoo
Mail
News
Taxes
Watchlists
My Portfolio
My Screeners
Market Data
Industry News
Real Estate
Technology
Currency Converter
Canada markets closed
S&P/TSX
22,465.37
+165.54
(+0.74%)
S&P 500
5,303.27
+6.17
(+0.12%)
DOW
40,003.59
+134.21
(+0.34%)
CAD/USD
0.7348
+0.0002
(+0.03%)
CRUDE OIL
80.00
+0.77
(+0.97%)
Bitcoin CAD
91,352.65
-341.53
(-0.37%)
Nymox Pharmaceutical Corporation (NYM.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.7500
0.0000
(0.00%)
At close: 08:29PM CEST
Summary
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
-5
0
0
5
Cost of Revenue
0
0
0
4
Gross Profit
-5
0
0
1
Operating Expenses
Research Development
-289
3,773
6,658
8,120
Selling General and Administrative
2,103
2,879
5,846
3,601
Total Operating Expenses
1,814
6,652
12,504
11,721
Operating Income or Loss
-1,819
-6,652
-12,504
-11,720
Interest Expense
-
43
39
42
Total Other Income/Expenses Net
-
118
-2
-3
Income Before Tax
-4,872
-6,576
-12,537
-11,738
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-4,872
-6,576
-12,537
-11,738
Net Income
-4,872
-6,576
-12,537
-11,738
Net Income available to common shareholders
-4,872
-6,576
-12,537
-11,738
Basic EPS
-
-
-
-0.16
Diluted EPS
-
-
-
-0.16
Basic Average Shares
-
-
-
73,823
Diluted Average Shares
-
-
-
73,823
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy Dashboard
About Our Ads
© 2024 Yahoo. All rights reserved.